RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling

被引:7
作者
Tolg, Cornelia [1 ]
Milojevic, Maja [2 ]
Qi, Freda W. [2 ]
Pavanel, Hailie A. [2 ]
Locke, M. Elizabeth O. [2 ,3 ]
Ma, Jenny [1 ]
Price, Mathew [4 ]
Nelson, Andrew C. [4 ]
McCarthy, James B. [4 ]
Hill, Kathleen A. [2 ,3 ]
Turley, Eva A. [1 ,5 ,6 ,7 ]
机构
[1] Lawson Hlth Res Inst, London Reg Canc Program, London, ON, Canada
[2] Western Univ, Dept Biol, London, ON, Canada
[3] Western Univ, Dept Comp Sci, London, ON, Canada
[4] Univ Minnesota, Masonic Canc Ctr, Lab Med & Pathol, Minneapolis, MN USA
[5] Western Univ, Dept Biochem, London, ON, Canada
[6] Western Univ, Dept Oncol, London, ON, Canada
[7] Western Univ, Dept Surg, London, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
RHAMM; HMMR; Lung metastasis; STING; Interferon; apoptosis; CANCER-CELLS; HYALURONAN; CD44; RECEPTOR; MODELS;
D O I
10.1186/s13058-023-01652-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundRHAMM is a multifunctional protein that is upregulated in breast tumors, and the presence of strongly RHAMM(+ve) cancer cell subsets associates with elevated risk of peripheral metastasis. Experimentally, RHAMM impacts cell cycle progression and cell migration. However, the RHAMM functions that contribute to breast cancer metastasis are poorly understood.MethodsWe interrogated the metastatic functions of RHAMM using a loss-of-function approach by crossing the MMTV-PyMT mouse model of breast cancer susceptibility with Rhamm(-/-) mice. In vitro analyses of known RHAMM functions were performed using primary tumor cell cultures and MMTV-PyMT cell lines. Somatic mutations were identified using a mouse genotyping array. RNA-seq was performed to identify transcriptome changes resulting from Rhamm-loss, and SiRNA and CRISPR/Cas9 gene editing was used to establish cause and effect of survival mechanisms in vitro.ResultsRhamm-loss does not alter initiation or growth of MMTV-PyMT-induced primary tumors but unexpectedly increases lung metastasis. Increased metastatic propensity with Rhamm-loss is not associated with obvious alterations in proliferation, epithelial plasticity, migration, invasion or genomic stability. SNV analyses identify positive selection of Rhamm(-/-) primary tumor clones that are enriched in lung metastases. Rhamm(-/-) tumor clones are characterized by an increased ability to survive with ROS-mediated DNA damage, which associates with blunted expression of interferon pathway and target genes, particularly those implicated in DNA damage-resistance. Mechanistic analyses show that ablating RHAMM expression in breast tumor cells by siRNA knockdown or CRISPR-Cas9 gene editing blunts interferon signaling activation by STING agonists and reduces STING agonist-induced apoptosis. The metastasis-specific effect of RHAMM expression-loss is linked to microenvironmental factors unique to tumor-bearing lung tissue, notably high ROS and TGFB levels. These factors promote STING-induced apoptosis of RHAMM(+ve) tumor cells to a significantly greater extent than RHAMM(-ve) comparators. As predicted by these results, colony size of Wildtype lung metastases is inversely related to RHAMM expression.ConclusionRHAMM expression-loss blunts STING-IFN signaling, which offers growth advantages under specific microenvironmental conditions of lung tissue. These results provide mechanistic insight into factors controlling clonal survival/expansion of metastatic colonies and has translational potential for RHAMM expression as a marker of sensitivity to interferon therapy.
引用
收藏
页数:17
相关论文
共 59 条
[1]   Current Landscape of Immunotherapy in Breast Cancer: A Review [J].
Adams, Sylvia ;
Gatti-Mays, Margaret E. ;
Kalinsky, Kevin ;
Korde, Larissa A. ;
Sharon, Elad ;
Amiri-Kordestani, Laleh ;
Bear, Harry ;
McArthur, Heather L. ;
Frank, Elizabeth ;
Perlmutter, Jane ;
Page, David B. ;
Vincent, Benjamin ;
Hayes, Jennifer F. ;
Gulley, James L. ;
Litton, Jennifer K. ;
Hortobagyi, Gabriel N. ;
Chia, Stephen ;
Krop, Ian ;
White, Julia ;
Sparano, Joseph ;
Disis, Mary L. ;
Mittendorf, Elizabeth A. .
JAMA ONCOLOGY, 2019, 5 (08) :1205-1214
[2]   Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? [J].
Alan Maxwell, Christopher ;
McCarthy, James ;
Turley, Eva .
JOURNAL OF CELL SCIENCE, 2008, 121 (07) :925-932
[3]   The scrambled story between hyaluronan and glioblastoma [J].
Arturo Pibuel, Matias ;
Poodts, Daniela ;
Diaz, Mariangeles ;
Elvira Hajos, Silvia ;
Laura Lompardia, Silvina .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
[4]   Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo [J].
Attalla, Sherif ;
Taifour, Tarek ;
Bui, Tung ;
Muller, William .
ONCOGENE, 2021, 40 (03) :475-491
[5]   Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis [J].
Bahrami, S. B. ;
Tolg, C. ;
Peart, T. ;
Symonette, C. ;
Veiseh, M. ;
Umoh, J. U. ;
Holdsworth, D. W. ;
McCarthy, J. B. ;
Luyt, L. G. ;
Bissell, M. J. ;
Yazdani, A. ;
Turley, E. A. .
INTEGRATIVE BIOLOGY, 2017, 9 (03) :223-237
[6]   The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression [J].
Banik, Sayantan ;
Rakshit, Sudeshna ;
Sarkar, Koustav .
JOURNAL OF BREAST CANCER, 2021, 24 (03) :253-265
[7]   HD-CNV: hotspot detector for copy number variants [J].
Butler, Jenna L. ;
Locke, Marjorie Elizabeth Osborne ;
Hill, Kathleen A. ;
Daley, Mark .
BIOINFORMATICS, 2013, 29 (02) :262-263
[8]   Increased RHAMM expression relates to ovarian cancer progression [J].
Buttermore, Stephanie T. ;
Hoffman, Mitchel S. ;
Kumar, Ambuj ;
Champeaux, Anne ;
Nicosia, Santo V. ;
Kruk, Patricia A. .
JOURNAL OF OVARIAN RESEARCH, 2017, 10
[9]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[10]   How cancer cells make and respond to interferon-I [J].
Cheon, HyeonJoo ;
Wang, Yuxin ;
Wightman, Samantha M. ;
Jackson, Mark W. ;
Stark, George R. .
TRENDS IN CANCER, 2023, 9 (01) :83-92